- Home
- CYBN vs SXTC Comparison
CYBN vs SXTC Comparison
Compare CYBN & SXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYBN
- SXTC
- Stock Information
- Founded
- CYBN 2019
- SXTC 2005
- Country
- CYBN Canada
- SXTC China
- Employees
- CYBN N/A
- SXTC N/A
- Industry
- CYBN Pharmaceuticals and Biotechnology
- SXTC Biotechnology: Pharmaceutical Preparations
- Sector
- CYBN Health Care
- SXTC Health Care
- Exchange
- CYBN Nasdaq
- SXTC Nasdaq
- Market Cap
- CYBN 176.5M
- SXTC 164.8M
- IPO Year
- CYBN N/A
- SXTC 2019
- Fundamental
- Price
- CYBN $6.08
- SXTC $1.99
- Analyst Decision
- CYBN Strong Buy
- SXTC
- Analyst Count
- CYBN 3
- SXTC 0
- Target Price
- CYBN $85.00
- SXTC N/A
- AVG Volume (30 Days)
- CYBN 621.7K
- SXTC 842.2K
- Earning Date
- CYBN 11-12-2025
- SXTC 01-01-0001
- Dividend Yield
- CYBN N/A
- SXTC N/A
- EPS Growth
- CYBN N/A
- SXTC N/A
- EPS
- CYBN N/A
- SXTC N/A
- Revenue
- CYBN N/A
- SXTC $1,740,907.00
- Revenue This Year
- CYBN N/A
- SXTC N/A
- Revenue Next Year
- CYBN N/A
- SXTC N/A
- P/E Ratio
- CYBN N/A
- SXTC N/A
- Revenue Growth
- CYBN N/A
- SXTC N/A
- 52 Week Low
- CYBN $4.81
- SXTC $0.95
- 52 Week High
- CYBN $13.88
- SXTC $7.84
- Technical
- Relative Strength Index (RSI)
- CYBN 38.92
- SXTC 66.47
- Support Level
- CYBN $6.16
- SXTC $1.33
- Resistance Level
- CYBN $6.55
- SXTC $1.69
- Average True Range (ATR)
- CYBN 0.49
- SXTC 0.19
- MACD
- CYBN -0.06
- SXTC 0.04
- Stochastic Oscillator
- CYBN 12.90
- SXTC 91.49
About CYBN Cybin Inc.
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The Company is a clinical-stage neuropsychiatric company focused on advancing therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions. The Company is developing technologies and delivery systems aimed at improving the pharmacokinetics of its proprietary molecules while retaining the therapeutic benefit. These new molecules and delivery systems are expected to be studied through clinical trials to confirm safety and efficacy.
About SXTC China SXT Pharmaceuticals Inc.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.